Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.

VPS33A anemia foamy podocyte lysosomal storage disease mucopolysaccharidosis mucopolysaccharidosis-plus syndrome proteinuria renal failure thrombocytopenia

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 May 2022
Historique:
received: 02 05 2022
revised: 18 05 2022
accepted: 22 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders (LSD) characterized by the excessive accumulation of glycosaminoglycans (GAG). Conventional MPS, caused by inborn deficiencies of lysosomal enzymes involved in GAG degradation, display various multisystemic symptoms-including progressive neurological complications, ophthalmological disorders, hearing loss, gastrointestinal and hepatobiliary issues, cardiorespiratory problems, bone and joint abnormalities, dwarfism, and coarse facial features. Mucopolysaccharidosis-Plus Syndrome (MPSPS), an autosomal recessive disease caused by a mutation in the endo-lysosomal tethering protein VPS33A, shows additional renal and hematopoietic abnormalities ("Plus symptoms") uncommon in conventional MPS. Here, we analyze data from biochemical, histological, and physical examinations-particularly of blood counts and kidney function-to further characterize the clinical phenotype of MPSPS. A series of blood tests indicate hematopoietic symptoms including progressive anemia and thrombocytopenia, which correlate with histological observations of hypoplastic bone marrow. High urinary excretion of protein (caused by impairments in renal filtration), hypoalbuminemia, and elevated levels of creatinine, cholesterol, and uric acid indicate renal dysfunction. Histological analyses of MPSPS kidneys similarly suggest the extensive destruction of glomerular structures by foamy podocytes. Height and weight did not significantly deviate from the average, but in some cases, growth began to decline at around six months or one year of age.

Identifiants

pubmed: 35628659
pii: ijms23105851
doi: 10.3390/ijms23105851
pmc: PMC9145135
pii:
doi:

Substances chimiques

Glycosaminoglycans 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : Scholarship
Organisme : Japan Society for the Promotion of Science
ID : JP17K05088
Organisme : Ministry Education and Science of Russian Federation
ID : FSRG-2020-0014

Références

Diagnostics (Basel). 2021 Feb 10;11(2):
pubmed: 33578874
Genes (Basel). 2022 Feb 28;13(3):
pubmed: 35327996
Clin Dysmorphol. 2017 Jan;26(1):1-12
pubmed: 27547915
Mol Genet Metab. 2011 Feb;102(2):170-5
pubmed: 21051253
Int J Mol Sci. 2020 Jan 09;21(2):
pubmed: 31936524
EMBO Mol Med. 2021 Feb 5;13(2):e12836
pubmed: 33459519
Cell Tissue Res. 2021 Aug;385(2):371-392
pubmed: 33433692
Hum Mol Genet. 2017 Jan 1;26(1):173-183
pubmed: 28013294
Nat Rev Nephrol. 2011 Mar;7(3):126
pubmed: 21473012
J Am Soc Nephrol. 2002 Jun;13 Suppl 2:S134-8
pubmed: 12068025
Intern Med. 2021 May 15;60(10):1561-1565
pubmed: 33361676
Hum Mol Genet. 2019 Aug 1;28(15):2514-2530
pubmed: 31070736
Traffic. 2015 Jul;16(7):727-42
pubmed: 25783203
Mod Pathol. 2006 Oct;19(10):1295-301
pubmed: 16799480
Nat Rev Dis Primers. 2018 Oct 1;4(1):27
pubmed: 30275469

Auteurs

Viktoriia Sofronova (V)

Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.
Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.

Rina Iwata (R)

Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.

Takuya Moriya (T)

Department of Pathology, Kawasaki Medical School, Kurashiki 701-0192, Japan.

Kiunniai Loskutova (K)

Department of Pathological Anatomy, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.
Medical Institute, North-Eastern Federal University, 677013 Yakutsk, Russia.

Elizaveta Gurinova (E)

Medical Genetics Center, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.

Mairanush Chernova (M)

Department of Children's Health and Pathological Anatomy, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.

Anastasia Timofeeva (A)

Department of Children's Health and Pathological Anatomy, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.

Anna Shvedova (A)

Department of Children's Health and Pathological Anatomy, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.

Filipp Vasilev (F)

Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.

Saina Novgorodova (S)

Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.

Seigo Terawaki (S)

Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.

Takahito Moriwaki (T)

Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.

Aitalina Sukhomyasova (A)

Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.
Medical Genetics Center, Republic Hospital No. 1-National Center of Medicine, 677019 Yakutsk, Russia.

Nadezhda Maksimova (N)

Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.

Takanobu Otomo (T)

Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH